Stevens Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Stevens Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,720	Closed	-$29K	–	1213
2016 Q2	$29K	Buy	+1,720	New	+$30.7K	﹤0.01%	869
2015 Q4	–	Sell	-19,124	Closed	-$365K	–	1216
2015 Q3	$365K	Buy	19,124 +16,415	+606%	+$557K	0.02%	629
2015 Q2	$126K	Buy	+2,709	New	+$118K	﹤0.01%	932
2015 Q1	–	Sell	-14,669	Closed	-$509K	–	1318
2014 Q4	$509K	Buy	14,669 +12,856	+709%	+$522K	0.02%	574
2014 Q3	$76K	Sell	1,813 -6,231	-77%	-$278K	﹤0.01%	949
2014 Q2	$471K	Buy	8,044 +5,089	+172%	+$320K	0.01%	685
2014 Q1	$186K	Sell	2,955 -3,205	-52%	-$213K	0.01%	938
2013 Q4	$360K	Sell	6,160 -7,419	-55%	-$388K	0.01%	738
2013 Q3	$716K	Buy	13,579 +10,285	+312%	+$691K	0.02%	556
2013 Q2	$254K	Buy	+3,294	New	+$269K	0.01%	751

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stevens Capital Management's ARNA Position: Q3 2016 in Review

Stevens Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2016, closing a stake of 1,720 shares — an estimated $29K sold.

Stevens Capital Management first reported a position in ARNA in Q2 2013 and held it in 10 quarters. The position peaked at $716K in Q3 2013. 125 funds tracked by Wall St. Rank hold ARNA as of Q3 2016.

Stevens Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Stevens Capital Management sold 1,720 Arena Pharmaceuticals Inc shares in Q3 2016, an estimated $29K.
Stevens Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
Stevens Capital Management's Arena Pharmaceuticals Inc position peaked at $716K in Q3 2013.
125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2016.

Based on Stevens Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.